International Journal of Radiation Oncology*Biology*Physics
ICTR 2003: Translational research in clinicsThree-dimensional conformal vs. intensity-modulated radiotherapy in head-and-neck cancer patients: comparative analysis of dosimetric and technical parameters☆
Introduction
When, in May 2001, the Oncology Institute of Southern Switzerland (IOSI) launched its program of intensity-modulated radiotherapy (IMRT), an internal feasibility protocol was activated by the radiation physics unit of this institution, mainly for head-and-neck tumors. This program was designed to prove technical reliability and dosimetric quality of IMRT in the environment of a nonacademic, intermediate-sized center: The IOSI is indeed equipped with 2 linear accelerators (only 1 with IMRT capabilities at the time), 1 conventional simulator, and 3D planning systems. About 600 new patients are treated each year by a medical and radiation physics staff dimensioned for such a work load, but with minimal “buffer” for heavy escalation of routine activities.
The aim of IMRT programs is essentially to improve, within above-mentioned logistic constraints, the irradiation of organs at risk and healthy tissue without compromising target irradiation (1). Importantly enough, another potential role of IMRT for dose escalation in head and neck, ascertained at planning levels (2), can be to reduce overall treatment time and to increase local control without compromising acute or late side effects. The selection of anatomic sites to include in the IMRT program at IOSI was based on the following criteria: global improvement of treatment (head and neck), resolution of specific problems of conventional techniques (breast with internal mammary chain irradiation), resolution of particularly complex single cases (brain), and dose escalation (head and neck).
As a further development of a previous phase carried out, at the planning level, for various anatomic sites 1, 2, 3, 4, this report will focus on the main technical and dosimetric issues to take into consideration in an early phase of the IMRT clinical implementation, with particular attention to head-and-neck cancer treatment.
Section snippets
Patient selection, volume definition, dose prescriptions
Between May 2001 and the end of March 2003, 42 patients were treated with IMRT corresponding to 61 dose plans or target volumes. Twenty-six patients presented head-and-neck cancer: 18 received whole IMRT treatments, and 8 received mixed IMRT and three-dimensional conformal radiotherapy (3DCRT) treatments (5), for a total of 42 IMRT plans. Of those, 20 were treated with static step-and-shoot and 6 with dynamic sliding window delivery modes. Five patients were treated for breast cancer (4 of them
Technical summary of treated fields
In Table 2 a, summary of some technical aspects of the IMRT irradiations performed at IOSI for head-and-neck patients is reported. The numbers of beams per plan (i.e., number of different gantry angles) were 3 (2 plans), 5 (10 plans), 7 (30 plans), and 9 (2 plans); the average was 6.8 ± 3.4. In the SS mode, the range of the number of segments per beam was 9–15 and of the MUs per segment was 3–14.
Patients treated with IMRT were fit into conventional time slots of 15 min per session, and no
Dosimetric issues
Delivered IMRT dose plans showed a systematic and highly significant improvement in terms of target coverage compared to reference 3DCRT. In particular, there was a huge improvement in both the point and significant minimum doses and in V90 and V95. According to nEUD, the biologic impact is potentially large and quantified in about 10%. All these results are extremely encouraging, because they prove, on dosimetric grounds, the advantage for head-and-neck patients with IMRT, even compared with
Conclusion
Based on a 2-year clinical experience with photon IMRT, dosimetric data of a comparison at plan level between treated IMRT and reference 3DCRT dose plans show the superiority of IMRT in terms of both target coverage (minimum doses to target, V90, V95 or EUD estimates) and organs at risk (spinal cord and parotids) sparing; the data indicate that further improvement can be expected for salivary gland protection. Logistically and technically, the implementation of IMRT in clinical practice can be
References (17)
- et al.
A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours
Radiother Oncol
(2001) - et al.
Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity mediation in head and neck cancer patients
Radiother Oncol
(2003) - et al.
Comparative analysis of intensity modulation inverse planning modules of three commercial treatment planning systems applied to head and neck tumour model
Radiother Oncol
(2003) - et al.
Critical appraisal of treatment techniques based on conventional photon beams, intensity modulated photon beams and proton beams for therapy of intact breast
Radiother Oncol
(2002) - et al.
Critical appraisal of a conformal head and neck cancer irradiation avoiding electron beams and field matching
Int J Radiat Oncol Biol Phys
(1999) - et al.
Tolerance of normal tissue to therapeutic irradiation
Int J Radiat Oncol Biol Phys
(1991) - et al.
X-ray field compensation with multileaf collimators
Int J Radiat Oncol Biol Phys
(1994) - ICRU. Prescribing, recording and reporting photon beam therapy. Report 50, International Commission on Radiation Units...
Cited by (0)
- ☆
The authors are grateful to Varian Medical Systems, International AG (Zug, Switzerland) for supporting a dedicated research program by providing the first clinical release of the Eclipse-HELIOS inverse treatment planning system. Part of the project was sponsored by the Swiss Federation against Cancer (OncoSuisse Grant No. 1151-09-2001).